Search Results for "survival-analysis"
-
Parlett LE
,
Ball K
,
Pipkin CA
,
Kappelman MD
,
Bocage C
,
Long MD
. Compared to thiopurines and tumor necrosis factor inhibitors novel biologics are associated with reduced risk of non-melanoma skin cancer among patients with inflammatory bowel disease
. Poster presented at
2024
International Society for Pharmacoepidemiology
Annual Meeting;
August 24 -
August 28, 2024;
.
-
Singh S
,
Li X
,
Cocoros NM
et al
. High-risk medications in persons living with dementia: a randomized clinical trial
.Jama Intern Med.
2024;
184
(12)
: 1426-33
. doi: 10.1001/jamainternmed.2024.5632
.
-
Adimadhyam S
,
Lewis JD
,
Simon AL
et al
. Real-world evidence comparing tofacitinib and vedolizumab in anti-tnf-experienced patients with ulcerative colitis
.Inflamm Bowel Dis.
2024;
30
(4)
: 554-62
. doi: 10.1093/ibd/izad115
.
-
Kappelman MD
,
Adimadhyam S
,
Hou L
et al
. Real-world evidence comparing vedolizumab and ustekinumab in antitumor necrosis factor-experienced patients with crohn's disease
.Am J Gastroenterol.
2023;
118
(4)
: 674-84
. doi: 10.14309/ajg.0000000000002068
.